Johnson & Johnson (JNJ) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 34.0% | 33.3% | 27.4% | 27.9% | 43.6% | 32.8% | ||
| Changes by years, y/y, % | +5pp | -1pp | -6pp | +1pp | +16pp | +8.5% | |||
Johnson & Johnson. EBITDA margin, %
Johnson & Johnson. EBITDA margin, changes, pp
Johnson & Johnson (JNJ) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 71.3% | 36.8% | 38.7% | 29.3% | 26.6% | 32.8% | |
| Changes by years, y/y, % | +45pp | +2pp | +15pp | +3pp | -45pp | |||
| Changes by quarters, q/q, % | +45pp | -34pp | +2pp | -9pp | -3pp | |||